Akantior
polihexanide
Acanthamoeba Keratitis
Opinion date:
Last updated:
MedicineHumanOpinion
Artesunate Amivas
artesunate
Malaria
Date of authorisation:
Revision: 4
Last updated:
MedicineHumanAuthorised
Eurartesim
piperaquine tetraphosphate
artenimol
Malaria
Date of authorisation:
Revision: 13
Last updated:
MedicineHumanAuthorised
Garsun
artesunate
Date of withdrawal:
Last updated:
MedicineHumanWithdrawn application
EMEA-001823-PIP01-15-M02 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Other
PIP number: P/0043/2021
Route(s) of administration: Intra-articular use
Pharmaceutical form(s):
Implantation matrix
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Artobend
autologous human chondrocytes in vitro expanded
Date of withdrawal:
Last updated:
MedicineHumanWithdrawn application
Maci - referral
matrix applied characterised autologous cultured chondrocytes
Article 20 procedures
Status: European Commission final decision
Opinion/position date:
EC decision date:
Last updated:
ReferralHuman
Maci
matrix-applied characterised autologous cultured chondrocytes
Fractures, Cartilage
Date of authorisation:
Date of refusal:
Revision: 4
Last updated:
MedicineHumanExpired
EMEA-000979-PIP01-10-M02 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Other
PIP number: P/0012/2018
Route(s) of administration: Implant use
Pharmaceutical form(s):
Implant
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-000153-PIP01-07-M05 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Infectious diseases
PIP number: P/0002/2018
Route(s) of administration: Oral use
Pharmaceutical form(s):
Film-coated tablet
Dispersible tablet
Decision date:
Last updated:
Compliance check: ✔
PIPHuman